Cargando…
Due to their anti-inflammatory, antioxidant and neurotrophic properties, second-generation antipsychotics are suitable in patients with schizophrenia and COVID-19
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141345/ https://www.ncbi.nlm.nih.gov/pubmed/34045093 http://dx.doi.org/10.1016/j.genhosppsych.2021.05.005 |
| _version_ | 1783696346451017728 |
|---|---|
| author | Tendilla-Beltrán, Hiram Flores, Gonzalo |
| author_facet | Tendilla-Beltrán, Hiram Flores, Gonzalo |
| author_sort | Tendilla-Beltrán, Hiram |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8141345 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81413452021-05-24 Due to their anti-inflammatory, antioxidant and neurotrophic properties, second-generation antipsychotics are suitable in patients with schizophrenia and COVID-19 Tendilla-Beltrán, Hiram Flores, Gonzalo Gen Hosp Psychiatry Letter to the Editor Elsevier Inc. 2021 2021-05-23 /pmc/articles/PMC8141345/ /pubmed/34045093 http://dx.doi.org/10.1016/j.genhosppsych.2021.05.005 Text en © 2021 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Tendilla-Beltrán, Hiram Flores, Gonzalo Due to their anti-inflammatory, antioxidant and neurotrophic properties, second-generation antipsychotics are suitable in patients with schizophrenia and COVID-19 |
| title | Due to their anti-inflammatory, antioxidant and neurotrophic properties, second-generation antipsychotics are suitable in patients with schizophrenia and COVID-19 |
| title_full | Due to their anti-inflammatory, antioxidant and neurotrophic properties, second-generation antipsychotics are suitable in patients with schizophrenia and COVID-19 |
| title_fullStr | Due to their anti-inflammatory, antioxidant and neurotrophic properties, second-generation antipsychotics are suitable in patients with schizophrenia and COVID-19 |
| title_full_unstemmed | Due to their anti-inflammatory, antioxidant and neurotrophic properties, second-generation antipsychotics are suitable in patients with schizophrenia and COVID-19 |
| title_short | Due to their anti-inflammatory, antioxidant and neurotrophic properties, second-generation antipsychotics are suitable in patients with schizophrenia and COVID-19 |
| title_sort | due to their anti-inflammatory, antioxidant and neurotrophic properties, second-generation antipsychotics are suitable in patients with schizophrenia and covid-19 |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141345/ https://www.ncbi.nlm.nih.gov/pubmed/34045093 http://dx.doi.org/10.1016/j.genhosppsych.2021.05.005 |
| work_keys_str_mv | AT tendillabeltranhiram duetotheirantiinflammatoryantioxidantandneurotrophicpropertiessecondgenerationantipsychoticsaresuitableinpatientswithschizophreniaandcovid19 AT floresgonzalo duetotheirantiinflammatoryantioxidantandneurotrophicpropertiessecondgenerationantipsychoticsaresuitableinpatientswithschizophreniaandcovid19 |